Open AccessLong-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy
Author(s) -
Xiaoyan Jiang,
Bing Huang,
Dan-Ping Huang,
Chunshan Wei,
Wu Zhong,
Deti Peng,
Furong Huang,
Guangdong Tong
Publication year - 2021
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v27.i11.1101
Subject(s) - hepatocellular carcinoma , medicine , cumulative incidence , incidence (geometry) , hepatitis b virus , antiviral therapy , gastroenterology , virology , oncology , virus , chronic hepatitis , cohort , physics , optics
China has a high prevalence of hepatitis B virus (HBV), but most chronic hepatitis B (CHB) patients do not receive standardized antiviral therapy. There are few relevant reports addressing the outcomes of the large number of CHB patients who do not receive antiviral therapy.